Intranasal administration

Patent metadata

Field	Value
Publication number	US-10940277-B2
Application number	US-201514946442-A
Country	US
Kind code	B2
Filing date	Nov 19, 2015
Priority date	Nov 19, 2014
Publication date	Mar 9, 2021
Grant date	Mar 9, 2021

Abstract

A nosepiece for delivering substance to a nasal cavity of a subject, the nosepiece comprising a body part which comprises a base portion which defines a flow passage therethrough, and a projection at a distal end of the base portion which at least in part provides a tip of the nosepiece and confers a rigidity in the sagittal direction, which enables the tip to open fleshy tissue at an upper region of the nasal valve and thereby expand an open area of the nasal valve, and a flexibility in a lateral direction, orthogonal to the sagittal plane, which facilitates insertion of the tip into the nasal valve.

First claim

The invention claimed is:

1. A nosepiece for delivering a substance to a nasal cavity of a subject, the nosepiece comprising:
an inner body part and an outer body part, the outer body part disposed about at least a portion of the inner body part and defining a tip, and the inner body part defining a flow path through the nosepiece and comprising:
a base portion having a distal end defining a substantially annular surface surrounding the flow path; and
a projection in the form of a blade having a length in the sagittal direction which is greater than a length in the lateral direction, the projection cantilevered from the distal end of the base portion that defines the substantially annular surface and extending toward and configured to support the tip of the outer body part;

wherein the tip is configured to open fleshy tissue at an upper region of the nasal valve of the subject and thereby expand an open area of the nasal valve.

2. The nosepiece of claim 1 , wherein the inner body part is formed of a plastic material.

3. The nosepiece of claim 1 , wherein the outer body part is formed of a resilient material.

4. The nosepiece of claim 3 , wherein the outer body part is formed of a thermoplastic elastomer (TPE).

5. The nosepiece of claim 1 , wherein the annular surface is inclined relative to a longitudinal axis of the nosepiece such that the base portion is shorter at a side which is opposite to the projection.

6. The nosepiece of claim 1 , wherein the projection extends axially in a direction substantially parallel to a longitudinal axis of the nosepiece.

7. The nosepiece of claim 1 , wherein the length of the projection in the sagittal direction is at least 1.5 times greater than the length in the lateral direction.

8. The nosepiece of claim 1 , wherein the length of the projection in the sagittal direction is at least 1.7 times greater than the length in the lateral direction.

9. The nosepiece of claim 1 , wherein the length of the projection in the sagittal direction is at least 1.9 times greater than the length in the lateral direction.

10. The nosepiece of claim 1 , wherein the length of the projection in the sagittal direction is at least 2 times greater than the length in the lateral direction.

11. The nosepiece of claim 1 , wherein the length of the projection in the sagittal direction is less than 3 mm.

12. The nosepiece of claim 1 , wherein the length of the projection in the sagittal direction is less than 2.5 mm.

13. The nosepiece of claim 1 , wherein the length of the projection in the sagittal direction is less than 1.5 mm.

14. The nosepiece of claim 1 , wherein the projection has a tapering lateral cross-section such that the length in the lateral direction decreases along the longitudinal extent of the projection approaching the distal end of the projection.

15. A nosepiece for delivering a substance to a nasal cavity of a subject, the nosepiece comprising:
an inner body part defining a flow path through the nosepiece, the inner body part comprising:
a base portion having a distal end defining a substantially annular surface surrounding the flow path; and
a projection in the form of a blade having a length in the sagittal direction which is greater than a length in the lateral direction, the projection cantilevered from the distal end of the base portion that defines the substantially annular surface and extending toward and configured to support a tip;

wherein the tip is configured to open fleshy tissue at an upper region of the nasal valve of the subject and thereby expand an open area of the nasal valve.

16. The nosepiece of claim 15 , wherein the substantially annular surface is inclined relative to a longitudinal axis of the nosepiece such that the base portion is shorter at a side which is opposite to the projection.

17. The nosepiece of claim 15 , wherein the projection extends axially in a direction substantially parallel to a longitudinal axis of the nosepiece.

Assignees

• Djupesland Per Gisle
• Sheldrake Colin David
• Optinose As

Inventors

• Djupesland Per Gisle
• Sheldrake Colin David

Classifications

• A61M15/0098

  Activated by exhalation · CPC title

• A61K38/08

  Peptides having 5 to 11 amino acids {(A61K38/043 - A61K38/046 take precedence)} · CPC title

• A61P25/00

  Drugs for disorders of the nervous system · CPC title

• A61K38/22 Primary

  Hormones (derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin A61K38/33, e.g. corticotropin A61K38/35) · CPC title

• A61M15/0021

  Mouthpieces therefor · CPC title